Novo Nordisk | NVO - EPS Earnings Per Share


Novo Nordisk reported DKK0.96 in EPS Earnings Per Share for its fiscal quarter ending in June of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q2 Jun/2026 0.96 0.80 0.93 Aug/04
FY2024Q3 Sep/2024 6.12 0.88 5.00 Nov/06
FY2024Q2 Jun/2024 4.49 4.32 Aug/07
FY2024Q1 Mar/2024 5.68 4.39 May/02
FY2023Q4 Dec/2023 0.72 0.67 6.02 Jan/31




Eps Change Date
ANI Pharmaceuticals USD 2.21 0.16 Jun/2026
Aurora Cannabis CAD -0.13 0.51 Mar/2026
Bausch Health Companies USD 1.26 0.48 Jun/2026
Bristol-Myers Squibb USD 2.04 0.46 Jun/2026
Canopy Growth CAD -0.4 0.35 Mar/2026
Corcept Therapeutics USD 0.36 0.66 Jun/2026
Drreddys Laboratories INR 0.06 0.1 Mar/2026
Eli Lilly USD 8.38 0.17 Jun/2026
GlaxoSmithKline GBP 0.51 0.08 Jun/2026
Merck USD -0.13 1.15 Jun/2026
Nektar Therapeutics USD -1.78 0.43 Mar/2026
Novartis USD 2.41 0.42 Jun/2026
Novo Nordisk DKK 4.74 6.17 Jun/2026
Novo Nordisk DKK 0.96 9.95 Jun/2026
Pacira USD 0.73 0.13 Jun/2026
Perrigo USD 0.5 0.07 Jun/2026
Phibro Animal Health USD 0.78 0.1 Dec/2025
Prestige Brands USD 0.98 0.25 Jun/2026
Sanofi EUR 2.09 0.21 Jun/2026
Supernus Pharmaceuticals USD -1.01 1.61 Jun/2026
Zoetis USD 1.87 0.34 Jun/2026